The Prediction Market for Women's Health & Culture
Sharp questions. Credible resolution. A community that actually knows the domain. Trade on what's next in femtech, fertility, wellness, policy, and culture.
First 500 members get 1,000 beta credits. No cash value.
Pre-launch beta. Play money. Real money later pending approvals.
Market Preview
Real questions. Clear resolution criteria. Odds shown are illustrative โ real trading begins in beta.
Will a major celebrity publicly share a menopause journey that goes viral in 2026?
Resolves: A celebrity's menopause/perimenopause post reaches 1M+ engagements on any platform.
Will a new non-hormonal menopause treatment receive full FDA approval in 2026?
Resolves: FDA grants full approval to a non-hormonal drug specifically for menopause symptoms. Verified via FDA.gov press releases.
Source: FDA.gov
Will women's longevity-focused interventions see a breakthrough funding round exceeding $100M in 2026?
Resolves: A women's longevity startup raises >$100M in a single round, per Crunchbase or similar.
Will microdosing GLP-1 drugs gain widespread use for PCOS management by end of 2026?
Resolves: At least two major health systems or professional organizations recommend GLP-1 for PCOS management.
Will egg freezing costs drop below $8,000 average in the US by end of 2026?
Resolves: Average cost tracked by FertilityIQ or similar authoritative source drops below $8,000.
Will AI-powered at-home diagnostics for endometriosis achieve clinical-grade accuracy in 2026?
Resolves: A peer-reviewed study reports >90% sensitivity and specificity for an AI-based endometriosis diagnostic.
Resolution you can audit
Every market includes a clear resolve-by date, specific criteria that decides yes vs. no, a primary resolution source, and a public record of the outcome. We don't do vibes. We do rules.
Resolve-by date
Every market has a deadline. No open-ended ambiguity.
Yes/No criteria
Specific conditions that decide the outcome. Published before trading opens.
Primary source
FDA.gov, Congress.gov, Crunchbase โ the source is named upfront.
Public record
Resolution decisions are logged with the evidence used. Fully auditable.
Clarity over volume
Weโd rather have 20 markets with bulletproof criteria than 200 with vague rules.
Domain expertise matters
Clinicians, researchers, and advocates who follow womenโs health are better forecasters on these questions.
Play money first, earn trust
Real-money trading comes only after regulatory approvals and a proven resolution process.
How are markets resolved?+
Can anyone change the result?+
Is this real money?+
Why ForecastHer exists
Prediction markets are powerful because they reward people who see clearly. But most markets ignore the questions women actually care about โ and when they do show up, the resolution rules are often vague.
ForecastHer is building a better standard: markets designed around women's health, femtech, women's sports, culture, and consumer trends, with resolution criteria you can audit.
We're starting with play-money beta credits. Real money comes later, only after the proper approvals. The point right now is simple: build the most credible forecasting community for women-led topics on the internet.
Get early access to the beta
First 500 members get 1,000 beta credits + founding status. No cash value.
No spam. Just markets worth arguing about and resolving cleanly.